Overview

Gender

female

Kay Noel has over 30 years experience in pharmaceutical development, with 10 NDA approvals. She has extensive experience in portfolio development, in-licensing, and out-licensing. Currently, she also serves as chief operating officer of Collaborative Medicinal Development LLC, a private company specializing in development of novel compounds for treatment of neurodegenerative diseases and cancer, with four ongoing clinical trials. Previous successful start-up and product development experiences include creation of the first healthcare business plan, managing a $75 million financing, and development and marketing of the first PCR kits at Cetus Corporation; co-founding and serving as vice president, commercial development for a novel oncology drug distribution system called Oncology Therapeutics Network, subsequently sold to Bristol Myers Squibb; and co-founding and serving as chief operating officer for OncoEthix SA, a cancer drug development company, subsequently sold to Merck.

Noel has a PhD in biophysics from the University of Michigan.